The Power to Change Lives
September 12, 2018
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
1 min read

September 12, 2018
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
1 min read
September 12, 2018
From big pharma, to cancer research, to joining a fast-growing CRO, James Hitchin has gained multiple perspectives on a subject that has become his passion – medicinal chemistry. Here, he reflects on the changing landscape within the UK, its impact on his career path, and the pitfalls and perks of the field.
1 min read
September 12, 2018
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better? Do you delay – or stick with it in the hope that it’s “good enough”?
1 min read
September 12, 2018
Pharma companies have ample room to improve productivity. Lean manufacturing and continuous improvement could be the key to success, and the automotive sector – Toyota, in particular – is a rich source of inspiration.
1 min read
September 12, 2018
The development of an optimized bioprocess requires a holistic approach tailored to the specific needs of the product.
1 min read
September 12, 2018
The fourth industrial revolution – Industry 4.0 – represents a shift in manufacturing mentality and is driven by intelligent automation, big data, applied machine learning, advanced analytics, and even virtual reality. The digital technology is already here, but is biopharma ready? The third – and final – article in our Biopharma Trends series seeks the answers.
1 min read
September 12, 2018
CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.
1 min read
September 12, 2018
“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.
1 min read
September 12, 2018
Global healthcare costs and demands are changing, and the next wave of complex biologics is entering biopharma pipelines. It is time to look beyond mammalian cell lines.
1 min read
September 12, 2018
Fighting counterfeit medicines is a noble goal, but the financial burden of safety features may affect access to medicines in unintended ways.
1 min read
False
False